Xiaoguang Luo - Publications

Affiliations: 
University of Nebraska Medical Center, Omaha, NE, United States 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wang XH, Xie X, Luo XG, Shang H, He ZY. Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease. Molecular Medicine Reports. PMID 28035410 DOI: 10.3892/mmr.2016.6070  0.304
2012 Luo XG, Chen SD. The changing phenotype of microglia from homeostasis to disease. Translational Neurodegeneration. 1: 9. PMID 23210447 DOI: 10.1186/2047-9158-1-9  0.308
2006 Luo XG, Wang H, Zhou J, Yan R, Wu Z, Zhang CD, Wang QS. Beneficial effects of BV2 cell on proliferation and neuron-differentiating of mesenchymal stem cells in the circumstance of injured PC12 cell supernatant. Neuroscience Bulletin. 22: 221-6. PMID 17704836  0.338
2003 Ikezu T, Luo X, Weber GA, Zhao J, McCabe L, Buescher JL, Ghorpade A, Zheng J, Xiong H. Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity. Journal of Neurochemistry. 85: 925-34. PMID 12716424 DOI: 10.1046/J.1471-4159.2003.01739.X  0.472
2003 Luo X, Weber GA, Zheng J, Gendelman HE, Ikezu T. C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease. Journal of Neuroimmunology. 135: 62-71. PMID 12576225 DOI: 10.1016/S0165-5728(02)00444-7  0.464
Show low-probability matches.